Tescarta car T cell emergency transplant
Ended Awarded
- Contract number
- 36C24921N0483
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $284,905
Award facts
- Contract value 100% obligated
- $284,904.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Foster City, CA 94404, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc., a biopharmaceutical company, for the provision of TESCARTA CAR T cell emergency transplant services. The contract, valued at $284,904.52, is not set aside and is issued under Gilead's existing GSA Schedule 61 contract for pharmaceuticals and drugs. Gilead will provide these oncology and pulmonary arterial hypertension medications directly to VA medical facilities and the Indian Health Service without any subcontractors. This contract award builds upon Gilead's prior work supplying the VA with other critical pharmaceuticals, including the COVID-19 treatment Veklury, as well as Yescarta, Tecartus, and Letairis for the treatment of various life-threatening conditions affecting veterans.
Quick answers
Who was awarded contract 36C24921N0483?
36C24921N0483 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on June 1, 2021.
How much is contract 36C24921N0483 worth?
The government has obligated $284,905 on 36C24921N0483.
Is contract 36C24921N0483 an order under another contract?
Yes. 36C24921N0483 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24921N0483 competed?
The extent of competition for 36C24921N0483 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award